临床微生物学与抗菌药物杂志

临床微生物学与抗菌药物杂志
开放获取

体积 8, 问题 1 (2024)

观点

Black Fungus and its Impact on Human Health

Jesmyn Vuong

分享此文章

观点

Black Fungus and its Impact on Human Health

Jesmyn Vuong

分享此文章

观点

Black Fungus and its Impact on Human Health

Jesmyn Vuong

分享此文章

观点

Black Fungus and its Impact on Human Health

Jesmyn Vuong

分享此文章

观点

Black Fungus and its Impact on Human Health

Jesmyn Vuong

分享此文章

研究文章

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

分享此文章

研究文章

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

分享此文章

研究文章

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

分享此文章

研究文章

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

分享此文章

研究文章

Meropenem Versus Ceftazidime-Avibactam Versus Ceftazidime-Avibactam with Aztreonam as Empiric, First-Line Treatment of High-Risk Febrile Neutropenia: First Report of the CAMerA Trial, an Open-Labelled, Randomized-Controlled Trial

Sachin Suresh Jadhav1*, Amey C Panchal1, Nishit Ojha1, Sonu Tony1, Jyothi Goutham Kumar2, Anjali Matani3 ,Yesheswini N Naik4

分享此文章
Top